← Back to Search

Participants with High Risk Early Breast Cancer for Breast Cancer

N/A
Recruiting
Research Sponsored by Exact Sciences Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

The EXActDNA-003 study will prospectively enroll participants who are planning to undergo chemotherapy for high-risk, early breast cancer, who are willing to provide tissue and blood specimens for circulating tumor DNA (ctDNA) analysis. Participants will be followed for up to 5.5 years.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Participants with High Risk Early Breast CancerExperimental Treatment1 Intervention
Participants with High Risk Early Breast Cancer

Find a Location

Who is running the clinical trial?

Exact Sciences CorporationLead Sponsor
34 Previous Clinical Trials
279,311 Total Patients Enrolled
2 Trials studying Breast Cancer
6,483 Patients Enrolled for Breast Cancer
NSABP Foundation IncNETWORK
88 Previous Clinical Trials
138,502 Total Patients Enrolled
45 Trials studying Breast Cancer
100,530 Patients Enrolled for Breast Cancer
~1200 spots leftby Apr 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top